Equinor: Auftaktquartal 2021 bringt bestes Ergebnis seit 2014 - Aktienanalyse (Raiffeisen Bank International AG) | Aktien des Tages aktiencheck.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aktiencheck.de Daily Mail and Mail on Sunday newspapers.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ORINTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY.
21st Austria weekly - Valneva Andritz Kapsch TrafficCom Raiffeisen Bank International Do&Co 10/06/2021 [pic1]Valneva: Austrian/French a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need today announced that it has completed recruitment clinical lot-to-lot consistency Phase 3 trial its single-shot chikungunya candidate VLA1553. VLA1553 is only candidate in trials at this time. 410 participants aged 18 to 45 years have been randomized VLA1553-302 will be followed total six months. The objective show manufacturing by demonstrating three consecutively manufactured lots elicit equivalent immune responses measured neutralizing antibody titers Day 29 after vaccination. Juan Carlos Jaramillo Chief Medical Officer Valneva
21st Austria weekly - OMV Lenzing Raiffeisen Bank International 08/06/2021 [pic1]OMV: the international integrated oil gas and chemicals company headquartered in Vienna Austria MOL Group a leading oil Budapest Hungary announced agreement for Group to acquire OMV Slovenia. The encompasses 120 filling stations as well OMV’s wholesale business transaction is subject required regulatory approvals closing expected 2022. agreed purchase price amounts Euro 301 mn 100% share.OMV: performance: -1.30% Lenzing: